Omega-3 Fish Oil
Salmon, sardines, mackerel, herring, anchovies.
Tag
Depression and low-mood references connect nutrient deficiency context, omega-3 evidence uncertainty, botanicals with interaction risks, and mood-related supplement topics. This page is not a depression treatment plan.
| Item | Type | Relationship | Evidence |
|---|---|---|---|
| Omega-3 Fish Oil | bioactive | Caution / Limited Evidence | NCCIH depression summaries describe omega-3 evidence as uncertain; high-dose omega-3s need bleeding-risk review. Traditional / Safety Reference |
| Saffron | bioactive | Caution / Limited Evidence | Existing saffron evidence is adjunct-like clinical context, not casual wellness guidance. Systematic Review |
| Vitamin B12 | nutrient | Deficiency Sign | Official NIH ODS B12 deficiency and neurologic-role framing. Official Reference |
| Folate | nutrient | May Support | Official NIH ODS folate framing; depression treatment claims need separate clinical evidence. Official Reference |
| Vitamin D | nutrient | Caution / Limited Evidence | Mood claims need stronger outcome-specific evidence; app uses official vitamin D source trail for safety and intake context. Official Reference |
| Iron | nutrient | Deficiency Sign | Official iron deficiency framing; do not self-treat with iron without testing. Official Reference |
| Ashwagandha | bioactive | Caution / Limited Evidence | Stress/anxiety evidence should not be generalized to depression treatment. Systematic Review |
Salmon, sardines, mackerel, herring, anchovies.
Saffron stigmas from Crocus sativus.
Meat and fish, Eggs and dairy foods, Fortified plant foods.
Leafy green vegetables, Legumes, Fortified grain products.
Fatty fish, Fortified milk or plant beverages, Egg yolk.
Red meat and shellfish, Legumes, Fortified cereals, Leafy greens.
Ashwagandha root.
Omega-3 supplements are studied for depression, but NCCIH says it is uncertain whether they help depression symptoms. | blood thinners | bleeding risk | surgery
Saffron has meta-analysis evidence in depressive-symptom contexts, but mood symptoms and antidepressant use require medical care and product/dose review. | pregnancy/breastfeeding | mood medications
Folate supports methylation and red blood cell formation; deficiency context can overlap with mood and fatigue evaluations. | The UL applies to folic acid from supplements and fortified foods, not naturally occurring food folate.
Vitamin D status is often discussed in mood contexts, but supplementation should follow ordinary DRI/UL, testing, and safety context rather than broad depression claims. | Avoid chronic high-dose use above the UL without medical supervision.
Iron deficiency can cause fatigue, low energy, and concentration issues that may overlap with low-mood complaints, but iron requires testing and cause-based evaluation. | Iron overdose can be dangerous, especially for children. High-dose use should be guided by a clinician.
Ashwagandha may affect stress measures, but depression, antidepressant use, thyroid disease, pregnancy, liver concerns, and sedative use need clinician review. | pregnancy/breastfeeding | thyroid disease | autoimmune disease
These are the dated references used for this tag. Live research searches can change; these links explain the fixed wording shown on this page.
National Center for Complementary and Integrative Health | Acquired 2026-08-03 | Traditional / Safety Reference
Depression complementary health safety, Omega-3 depression evidence uncertainty, St. John's wort interaction warning.
National Center for Complementary and Integrative Health | Acquired 2026-08-03 | Traditional / Safety Reference
Depression supplement evidence limitations, SAMe evidence limitations, St. John's wort medication interactions.
NIH Office of Dietary Supplements | Acquired 2026-07-23 | Official Reference
ALA AI, EPA/DHA no official DRI, Fish, krill, algal, and plant omega sources.
PubMed Central | Acquired 2026-07-26 | Systematic Review
Saffron, Depressive symptoms, Mood evidence limitations.
NIH Office of Dietary Supplements | Acquired 2026-07-23 | Official Reference
Cobalamin forms, B12 supplement forms, B12 absorption context.
NIH Office of Dietary Supplements | Acquired 2026-07-23 | Official Reference
Food folate, Folic acid, 5-MTHF.
Health Canada | Acquired 2026-07-23 | Official Reference
Canadian DRI table display, Vitamin D and K reference values, Vitamin K no-UL caution.
European Food Safety Authority | Acquired 2026-07-23 | Official Reference
EU vitamin D adequate intake, 25(OH)D target context, Minimal sun exposure assumption.
NIH Office of Dietary Supplements | Acquired 2026-07-23 | Official Reference
Heme and non-heme iron, Iron supplement forms, Elemental iron context.
NIH Office of Dietary Supplements | Acquired 2026-08-03 | Official Reference
Iron deficiency symptoms, Iron deficiency anemia, Iron overdose warning.
Phytotherapy Research / PubMed | Acquired 2026-07-23 | Systematic Review
Ashwagandha stress evidence, Ashwagandha anxiety evidence.
U.S. Food and Drug Administration | Acquired 2026-07-23 | Government Health Agency
Supplement-medication interaction warning language.
Folate supports methylation and red blood cell formation; deficiency context can overlap with mood and fatigue evaluations.
Evidence note: Official NIH ODS folate framing; depression treatment claims need separate clinical evidence.
Sources: Folate Fact Sheet for Health Professionals (2026-07-23)Official Reference, Depression and Complementary Health Approaches: What the Science Says (2026-08-03)Traditional / Safety Reference
Vitamin B12 deficiency can include neurologic, cognitive, and mood-related symptoms and belongs in low-mood evaluation context.
Evidence note: Official NIH ODS B12 deficiency and neurologic-role framing.
Sources: Vitamin B12 Fact Sheet for Health Professionals (2026-07-23)Official Reference
Iron deficiency can cause fatigue, low energy, and concentration issues that may overlap with low-mood complaints, but iron requires testing and cause-based evaluation.
Evidence note: Official iron deficiency framing; do not self-treat with iron without testing.
Sources: Iron Fact Sheet for Health Professionals (2026-07-23)Official Reference, Iron Fact Sheet for Consumers (2026-08-03)Official Reference
Omega-3 supplements are studied for depression, but NCCIH says it is uncertain whether they help depression symptoms.
Evidence note: NCCIH depression summaries describe omega-3 evidence as uncertain; high-dose omega-3s need bleeding-risk review.
Sources: 8 Things To Know About Depression and Complementary Health Approaches (2026-08-03)Traditional / Safety Reference, Depression and Complementary Health Approaches: What the Science Says (2026-08-03)Traditional / Safety Reference, Omega-3 Fatty Acids Fact Sheet for Health Professionals (2026-07-23)Official Reference
Saffron has meta-analysis evidence in depressive-symptom contexts, but mood symptoms and antidepressant use require medical care and product/dose review.
Evidence note: Existing saffron evidence is adjunct-like clinical context, not casual wellness guidance.
Sources: Saffron and Major Depressive Disorder: A Meta-Analysis of Randomized Clinical Trials (2026-07-26)Systematic Review, 8 Things To Know About Depression and Complementary Health Approaches (2026-08-03)Traditional / Safety Reference
Vitamin D status is often discussed in mood contexts, but supplementation should follow ordinary DRI/UL, testing, and safety context rather than broad depression claims.
Evidence note: Mood claims need stronger outcome-specific evidence; app uses official vitamin D source trail for safety and intake context.
Sources: Dietary Reference Intakes Tables: Reference Values for Vitamins (2026-07-23)Official Reference, Dietary Reference Values for Vitamin D (2026-07-23)Official Reference, 8 Things To Know About Depression and Complementary Health Approaches (2026-08-03)Traditional / Safety Reference
Ashwagandha may affect stress measures, but depression, antidepressant use, thyroid disease, pregnancy, liver concerns, and sedative use need clinician review.
Evidence note: Stress/anxiety evidence should not be generalized to depression treatment.
Sources: Ashwagandha Supplementation for Anxiety and Stress: Systematic Review and Meta-Analysis (2026-07-23)Systematic Review, 8 Things To Know About Depression and Complementary Health Approaches (2026-08-03)Traditional / Safety Reference, Mixing Medications and Dietary Supplements Can Endanger Your Health (2026-07-23)Government Health Agency